Focal nodular hyperplasia: Hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI

Abdominal Imaging

Volumn 38, Issue 3, 2013, Pages 490-501

  Van Kessel, C S ^a   De Boer, E ^a   Ten Kate, F J W ^a   Brosens, L A A ^a   Veldhuis, W B ^a   Van Leeuwen, M S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Enhancement characteristics; Focal nodular hyperplasia; Gadoxetic acid; Histology; Magnetic resonance imaging

Indexed keywords

GADOXETIC ACID; CD34 ANTIGEN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BILE DUCT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; MALE; METAPLASIA; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; DIAGNOSTIC USE; FOCAL NODULAR HYPERPLASIA; HEPATOBILIARY SYSTEM; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; PATHOLOGY;

ANTIGENS, CD34; BILIARY TRACT; CONTRAST MEDIA; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; LIVER; MAGNETIC RESONANCE IMAGING;

EID: 84879088001     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9916-0     Document Type: Article

References (25)

1. Buell JF, Tranchart H, Cannon R, Dagher I (2010) Management of benign hepatic tumors. Surg Clin North Am 90:719-735
2. Ishak KG, Goodman ZD, Stocker JT (2001) Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology
3. Kerlin P, Davis GL, McGill DB, et al. (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84:994-1002
4. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441-1454
5. Kondo F, Nagao T, Sato T, et al. (1998) Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 194:487-495
6. Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194-1200
7. Butron VMM, Haot J, Desmet VJ (1984) Cholestatic features in focal nodular hyperplasia. Liver 4:387-395
8. van Eyken P, Sciot R, Callea F, Desmet VJ (1989) A cytokeratin- immunohistochemical study of focal nodular hyperplasia of the liver: further evidence that ductular metaplasia of hepatocytes contributes to ductular "proliferation". Liver 9:372-377
9. Weimann A, Ringe B, Klempnauer J, et al. (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21:983-990
10. Bartolotta TV, Midiri M, Scialpi M, et al. (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583-591
11. Bartolotta TV, Midiri M, Quaia E, et al. (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643-1649
12. Bartolotta TV, Taibbi A, Matranga D, et al. (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20:2248-2256
13. Herman P, Pugliese V, Machado MA, et al. (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24:372-376
14. Hussain SM, Terkivatan T, van Zonder PE, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3-17
15. Mortele KJ, Praet M, Van VH, et al. (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27:700-707
16. Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J (1994) Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 19:34-38
17. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504-511
18. Ba-Ssalamah A, Schima W, Schmook MT, et al. (2002) Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179:1447-1456
19. Choi CS, Freeny PC (1998) Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 170:391-395
20. Uggowitzer MM, Kugler C, Ruppert-Kohlmayr A, et al. (2000) Current status of diagnostic imaging of focal nodular hyperplasia of the liver. Rofo 172:727-738
21. Vilgrain V, Flejou JF, Arrive L, et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699-703
22. Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177-183
23. Tsuboyama T, Onishi H, Kim T, et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824-833
24. Kondo F (2001) Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 16:1319-1328
25. Slott PA, Liu MH, Tavoloni N (1990) Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 99:466-477